Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8201 - 8208 of 12142 results
Anti-Steering Restrictions in Payor Contracts Face Antitrust Challenge by DOJ and NC
June 10, 2016| Blog| Viewpoint
End Isn't Nigh For FCC Rules On Local TV Station Deals
June 10, 2016| News
Federal Court Declines to Exercise Jurisdiction Over Toshiba Despite Over-the-Counter ADS Sales in the United States
June 9, 2016| Blog| Viewpoint
Legislation to Reduce Consumer Cost-Sharing Takes a Back Burner in the Drug Pricing Debate
June 9, 2016| Blog| Viewpoint
Employers, Join Us for a Webinar: The New White-Collar Overtime Rule
June 9, 2016| Blog| Viewpoint
Tackling the Dragon of Hospital Price Disparity: Massachusetts's On-Going Efforts to Address Price Equity
June 8, 2016| Alert| Viewpoint
Senate Appropriations Bill Targets FDA Rulemaking Agenda
June 8, 2016| Blog| Viewpoint
As Affordable Care Act Enforcement Looms, Some Lessons Learned From Massachusetts
June 8, 2016| Blog| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts
Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|
Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|